SKYE BIOSCIENCE INC (SKYE) Stock Analyst Ratings
NASDAQ:SKYE - Nasdaq - US83086J2006 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to SKYE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.36. This target is 535.29% above the current price.
SKYE was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SKYE.
In the previous month the buy percentage consensus was at a similar level.
SKYE was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-30 | ScotiaBank | Initiate | Sector Outperform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-20 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-10 | JMP Securities | Initiate | Market Outperform |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-09 | Craig-Hallum | Initiate | Buy |
| 2024-07-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-23 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-04-12 | Oppenheimer | Initiate | Outperform |